Bridgewater Associates LP Sells 47,555 Shares of Cabot Co. (NYSE:CBT)

Bridgewater Associates LP reduced its holdings in shares of Cabot Co. (NYSE:CBT - Free Report) by 81.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,508 shares of the specialty chemicals company's stock after selling 47,555 shares during the quarter. Bridgewater Associates LP's holdings in Cabot were worth $959,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Ontario Teachers Pension Plan Board lifted its stake in Cabot by 105.2% in the 4th quarter. Ontario Teachers Pension Plan Board now owns 21,623 shares of the specialty chemicals company's stock worth $1,974,000 after purchasing an additional 11,084 shares in the last quarter. Hanlon Investment Management Inc. bought a new position in shares of Cabot during the 4th quarter valued at $601,000. Barclays PLC grew its holdings in shares of Cabot by 38.1% during the 4th quarter. Barclays PLC now owns 156,908 shares of the specialty chemicals company's stock valued at $14,327,000 after purchasing an additional 43,294 shares during the last quarter. Neuberger Berman Group LLC grew its holdings in shares of Cabot by 1.2% during the 4th quarter. Neuberger Berman Group LLC now owns 18,238 shares of the specialty chemicals company's stock valued at $1,665,000 after purchasing an additional 212 shares during the last quarter. Finally, LSV Asset Management grew its holdings in Cabot by 40.5% in the 4th quarter. LSV Asset Management now owns 136,600 shares of the specialty chemicals company's stock worth $12,473,000 after acquiring an additional 39,400 shares during the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CBT. UBS Group reduced their price target on Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a report on Monday, April 7th. JPMorgan Chase & Co. lowered their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st. StockNews.com raised Cabot from a "hold" rating to a "buy" rating in a research report on Thursday, April 17th. Finally, Mizuho reduced their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a report on Tuesday, January 7th.

Cabot Stock Up 1.6 %

CBT traded up $1.29 during trading on Thursday, hitting $79.69. 82,636 shares of the company's stock traded hands, compared to its average volume of 387,908. The company's 50 day simple moving average is $82.25 and its two-hundred day simple moving average is $94.24. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. Cabot Co. has a 12-month low of $73.63 and a 12-month high of $117.46. The stock has a market capitalization of $4.32 billion, a price-to-earnings ratio of 10.58, a PEG ratio of 0.74 and a beta of 1.04.

Cabot (NYSE:CBT - Get Free Report) last issued its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Analysts predict that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.